⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EYPT News
EyePoint Pharmaceuticals, Inc. Common Stock
EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026
globenewswire.com
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema
globenewswire.com
EYPT
EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026
globenewswire.com
EYPT